Global Point-of-care Testing (POCT) for Chronic Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Chronic Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Chronic Disease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Chronic Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Chronic Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BioMerieux, Siemens Healthineers, Roche and Danaher, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Chronic Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Point-of-care Testing (POCT) for Chronic Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Chronic Disease, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Chronic Disease from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Chronic Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Chronic Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Chronic Disease market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Chronic Disease.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Chronic Disease sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Chronic Disease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Chronic Disease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Chronic Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Chronic Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BioMerieux, Siemens Healthineers, Roche and Danaher, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Chronic Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Based on Immunochromatography
- Based on Chemiluminescence Technology
- Based on Biosensor
- Others
- Hospital
- lndependent Testing Organization
- Abbott
- BioMerieux
- Siemens Healthineers
- Roche
- Danaher
- Sinocare Inc
- Assure Tech (Hangzhou) Co.,Ltd.
- Bio-Rad Laboratories
- Guangzhou Wondfo Biotech Co.,Ltd.
- Wuhan Easy Diagnosis Biomedicine Co.,ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Point-of-care Testing (POCT) for Chronic Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Chronic Disease, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Chronic Disease from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Chronic Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Chronic Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Chronic Disease market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Chronic Disease.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Chronic Disease sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Chronic Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Immunochromatography
1.3.3 Based on Chemiluminescence Technology
1.3.4 Based on Biosensor
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Chronic Disease Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.1.4 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.2.4 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioMerieux Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.4.4 Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Recent Developments/Updates
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.5.4 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Danaher Recent Developments/Updates
2.6 Sinocare Inc
2.6.1 Sinocare Inc Details
2.6.2 Sinocare Inc Major Business
2.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.6.4 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinocare Inc Recent Developments/Updates
2.7 Assure Tech (Hangzhou) Co.,Ltd.
2.7.1 Assure Tech (Hangzhou) Co.,Ltd. Details
2.7.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
2.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.7.4 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Laboratories Recent Developments/Updates
2.9 Guangzhou Wondfo Biotech Co.,Ltd.
2.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
2.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
2.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
2.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Chronic Disease Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Chronic Disease Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Chronic Disease Market Drivers
12.2 Point-of-care Testing (POCT) for Chronic Disease Market Restraints
12.3 Point-of-care Testing (POCT) for Chronic Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Chronic Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Chronic Disease
13.3 Point-of-care Testing (POCT) for Chronic Disease Production Process
13.4 Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
14.3 Point-of-care Testing (POCT) for Chronic Disease Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Chronic Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Immunochromatography
1.3.3 Based on Chemiluminescence Technology
1.3.4 Based on Biosensor
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Chronic Disease Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.1.4 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.2.4 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioMerieux Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.4.4 Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Recent Developments/Updates
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.5.4 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Danaher Recent Developments/Updates
2.6 Sinocare Inc
2.6.1 Sinocare Inc Details
2.6.2 Sinocare Inc Major Business
2.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.6.4 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinocare Inc Recent Developments/Updates
2.7 Assure Tech (Hangzhou) Co.,Ltd.
2.7.1 Assure Tech (Hangzhou) Co.,Ltd. Details
2.7.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
2.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.7.4 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Laboratories Recent Developments/Updates
2.9 Guangzhou Wondfo Biotech Co.,Ltd.
2.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
2.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
2.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
2.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Chronic Disease Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Chronic Disease Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Chronic Disease Market Drivers
12.2 Point-of-care Testing (POCT) for Chronic Disease Market Restraints
12.3 Point-of-care Testing (POCT) for Chronic Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Chronic Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Chronic Disease
13.3 Point-of-care Testing (POCT) for Chronic Disease Production Process
13.4 Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
14.3 Point-of-care Testing (POCT) for Chronic Disease Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 6. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 9. BioMerieux Major Business
Table 10. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 11. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BioMerieux Recent Developments/Updates
Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthineers Major Business
Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Siemens Healthineers Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 21. Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Roche Recent Developments/Updates
Table 23. Danaher Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Major Business
Table 25. Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 26. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Danaher Recent Developments/Updates
Table 28. Sinocare Inc Basic Information, Manufacturing Base and Competitors
Table 29. Sinocare Inc Major Business
Table 30. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 31. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinocare Inc Recent Developments/Updates
Table 33. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 35. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 36. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 38. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Rad Laboratories Major Business
Table 40. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 41. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Rad Laboratories Recent Developments/Updates
Table 43. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 45. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 46. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 48. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 50. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 51. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 53. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Point-of-care Testing (POCT) for Chronic Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Point-of-care Testing (POCT) for Chronic Disease Production Site of Key Manufacturer
Table 58. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
Table 59. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
Table 60. Point-of-care Testing (POCT) for Chronic Disease New Market Entrants and Barriers to Market Entry
Table 61. Point-of-care Testing (POCT) for Chronic Disease Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Point-of-care Testing (POCT) for Chronic Disease Raw Material
Table 121. Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease Raw Materials
Table 122. Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
Table 123. Point-of-care Testing (POCT) for Chronic Disease Typical Customers
Table 1. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 6. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 9. BioMerieux Major Business
Table 10. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 11. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BioMerieux Recent Developments/Updates
Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthineers Major Business
Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Siemens Healthineers Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 21. Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Roche Recent Developments/Updates
Table 23. Danaher Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Major Business
Table 25. Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 26. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Danaher Recent Developments/Updates
Table 28. Sinocare Inc Basic Information, Manufacturing Base and Competitors
Table 29. Sinocare Inc Major Business
Table 30. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 31. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinocare Inc Recent Developments/Updates
Table 33. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 35. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 36. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 38. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Rad Laboratories Major Business
Table 40. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 41. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Rad Laboratories Recent Developments/Updates
Table 43. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 45. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 46. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 48. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 50. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 51. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 53. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Point-of-care Testing (POCT) for Chronic Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Point-of-care Testing (POCT) for Chronic Disease Production Site of Key Manufacturer
Table 58. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
Table 59. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
Table 60. Point-of-care Testing (POCT) for Chronic Disease New Market Entrants and Barriers to Market Entry
Table 61. Point-of-care Testing (POCT) for Chronic Disease Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Point-of-care Testing (POCT) for Chronic Disease Raw Material
Table 121. Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease Raw Materials
Table 122. Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
Table 123. Point-of-care Testing (POCT) for Chronic Disease Typical Customers
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Chronic Disease Picture
Figure 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type in 2022
Figure 4. Based on Immunochromatography Examples
Figure 5. Based on Chemiluminescence Technology Examples
Figure 6. Based on Biosensor Examples
Figure 7. Others Examples
Figure 8. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. lndependent Testing Organization Examples
Figure 12. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 54. China Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Point-of-care Testing (POCT) for Chronic Disease Market Drivers
Figure 75. Point-of-care Testing (POCT) for Chronic Disease Market Restraints
Figure 76. Point-of-care Testing (POCT) for Chronic Disease Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease in 2022
Figure 79. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
Figure 80. Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Chronic Disease Picture
Figure 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type in 2022
Figure 4. Based on Immunochromatography Examples
Figure 5. Based on Chemiluminescence Technology Examples
Figure 6. Based on Biosensor Examples
Figure 7. Others Examples
Figure 8. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. lndependent Testing Organization Examples
Figure 12. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 54. China Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Point-of-care Testing (POCT) for Chronic Disease Market Drivers
Figure 75. Point-of-care Testing (POCT) for Chronic Disease Market Restraints
Figure 76. Point-of-care Testing (POCT) for Chronic Disease Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease in 2022
Figure 79. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
Figure 80. Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
